219 related articles for article (PubMed ID: 21377288)
1. Estimation of α/β for late rectal toxicity based on RTOG 94-06.
Tucker SL; Thames HD; Michalski JM; Bosch WR; Mohan R; Winter K; Cox JD; Purdy JA; Dong L
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):600-5. PubMed ID: 21377288
[TBL] [Abstract][Full Text] [Related]
2. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
3. Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.
Tucker SL; Dong L; Michalski JM; Bosch WR; Winter K; Cox JD; Purdy JA; Mohan R
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):390-5. PubMed ID: 22342302
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
[TBL] [Abstract][Full Text] [Related]
5. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
Moore KL; Schmidt R; Moiseenko V; Olsen LA; Tan J; Xiao Y; Galvin J; Pugh S; Seider MJ; Dicker AP; Bosch W; Michalski J; Mutic S
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):228-35. PubMed ID: 25847605
[TBL] [Abstract][Full Text] [Related]
6. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
[TBL] [Abstract][Full Text] [Related]
7. Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.
Tucker SL; Michalski JM; Bosch WR; Mohan R; Dong L; Winter K; Purdy JA; Cox JD
Radiother Oncol; 2012 Jul; 104(1):109-13. PubMed ID: 22673726
[TBL] [Abstract][Full Text] [Related]
8. Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.
Tucker SL; Dong L; Bosch WR; Michalski J; Winter K; Mohan R; Purdy JA; Kuban D; Lee AK; Cheung MR; Thames HD; Cox JD
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1253-60. PubMed ID: 20598811
[TBL] [Abstract][Full Text] [Related]
9. Random forests to predict rectal toxicity following prostate cancer radiation therapy.
Ospina JD; Zhu J; Chira C; Bossi A; Delobel JB; Beckendorf V; Dubray B; Lagrange JL; Correa JC; Simon A; Acosta O; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1024-1031. PubMed ID: 25035205
[TBL] [Abstract][Full Text] [Related]
10. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
[TBL] [Abstract][Full Text] [Related]
11. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
[TBL] [Abstract][Full Text] [Related]
12. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
Cheung R; Tucker SL; Ye JS; Dong L; Liu H; Huang E; Mohan R; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1513-9. PubMed ID: 15050331
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
14. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
[TBL] [Abstract][Full Text] [Related]
15. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
Boersma LJ; van den Brink M; Bruce AM; Shouman T; Gras L; te Velde A; Lebesque JV
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):83-92. PubMed ID: 9588921
[TBL] [Abstract][Full Text] [Related]
16. Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.
Gulliford SL; Partridge M; Sydes MR; Webb S; Evans PM; Dearnaley DP
Radiother Oncol; 2012 Mar; 102(3):347-51. PubMed ID: 22119373
[TBL] [Abstract][Full Text] [Related]
17. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
[TBL] [Abstract][Full Text] [Related]
18. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
[TBL] [Abstract][Full Text] [Related]
19. Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial.
Brand DH; Brüningk SC; Wilkins A; Fernandez K; Naismith O; Gao A; Syndikus I; Dearnaley DP; Tree AC; van As N; Hall E; Gulliford S;
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):596-608. PubMed ID: 33412260
[TBL] [Abstract][Full Text] [Related]
20. Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.
Marzi S; Saracino B; Petrongari MG; Arcangeli S; Gomellini S; Arcangeli G; Benassi M; Landoni V
J Exp Clin Cancer Res; 2009 Aug; 28(1):117. PubMed ID: 19689825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
